Press Releases - 2021-12-22

Date	Title	Company
22-Dec-2021	Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million	Biophytis
22-Dec-2021	Survey shows US health care providers lack trust in drug-related marketing content provided by pharmaceutical companies	Three Whiskey
22-Dec-2021	ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention	ViiV Healthcare
22-Dec-2021	National Institute for Health and Care Excellence Backs Darzalex®▼ (daratumumab) in Combination with Velcade® (bortezomib), Thalidomide and Dexamethasone (DVTd) for Patients with Newly Diagnosed Multiple Myeloma	Janssen Pharmaceutical Companies of Johnson & Johnson
22-Dec-2021	EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®)	EXACT Therapeutics AS
22-Dec-2021	Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals	Arix Bioscience
22-Dec-2021	Qualer Has Added New Automation Software Features for Their Asset Maintenance Software Solutions	Newswire
22-Dec-2021	IoM Hospice and digital health company leading clinical study to inform global dementia care	Memory Lane Games
22-Dec-2021	Gyroscope Therapeutics to be acquired for up to $1.5 billion	Gyroscope Therapeutics
22-Dec-2021	Medpoint secures finance to provide innovative tech for pharmacies	Medpoint
22-Dec-2021	Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Receives FDA Fast Track Designation for Varoglutamstat in Early Alzheimer's Disease (news with additional features)	Vivoryon Therapeutics N.V.